The image provides a comprehensive overview of Age-related Macular Degeneration (AMD), including its risk factors and a progression scale with corresponding fundus characteristics. Based on the information presented in the image, which of the following statements accurately describes the key change in fundus findings when progressing from Early AMD (Grade 2) to Intermediate AMD (Grade 3)?

Explanation

## Image Findings * Diagram illustrating the progression of Age-related Macular Degeneration (AMD) through different grades. * Specific criteria for each AMD grade, including drusen size, presence of pigmentary abnormalities, and dark adaptation status. * Fundus images depicting the characteristic appearance of each AMD grade. * Risk factors associated with AMD development are also shown. ## Diagnosis **Key Point:** The progression from Early AMD (Grade 2) to Intermediate AMD (Grade 3) is primarily marked by an increase in drusen size. The image clearly outlines the diagnostic criteria for each stage of AMD. **Early AMD (Grade 2)** is characterized by **small or medium drusen (<125 µm)** and **AMD pigmentary abnormalities**, along with impaired dark adaptation. **Intermediate AMD (Grade 3)** is defined by the presence of **large drusen (>125 µm)**, in addition to AMD pigmentary abnormalities and impaired dark adaptation. Therefore, the increase in drusen size is the distinguishing feature in this transition. ## Differential Diagnosis | Feature | Early AMD (Grade 2) | Intermediate AMD (Grade 3) | Advanced AMD (Grade 4/5) | | :--------------------------- | :---------------------------------------- | :---------------------------------------- | :--------------------------------------- | | **Drusen Size** | Small or medium (<125 µm) | Large (>125 µm) | Large drusen often coalescing | | **Pigmentary Abnormalities** | Present | Present | Present, often severe | | **Dark Adaptation** | Impaired | Impaired | Severely impaired | | **Key Pathological Event** | Drusen accumulation | Significant drusen accumulation | Geographic atrophy OR Neovascularization | ## Clinical Relevance **Clinical Pearl:** Early detection and monitoring of drusen size and pigmentary changes are crucial for managing AMD progression. Lifestyle modifications and nutritional supplements (AREDS formula) are often recommended for intermediate AMD to slow progression to advanced stages. ## High-Yield for NEET PG **High-Yield:** The presence of **large drusen (>125 µm)** is a key indicator for Intermediate AMD and a significant risk factor for progression to advanced forms. **Key Point:** Impaired dark adaptation can be an early functional sign of AMD, even before significant drusen are visible. ## Common Traps **Warning:** Confusing the criteria for drusen size between early and intermediate stages, or attributing advanced features like neovascularization or geographic atrophy to earlier stages, is a common trap. Always refer to the specific drusen size cutoffs and the presence/absence of atrophy or neovascularization for accurate staging. ## Reference [cite:Kanski's Clinical Ophthalmology, Chapter 15: Macular Diseases]